{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T10:04:30Z","timestamp":1785492270627,"version":"3.56.0"},"reference-count":29,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T00:00:00Z","timestamp":1753574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Several epidemiological studies have indicated that metabolic syndrome (MetS) after renal transplantation is caused by an accumulation of non-immunological risks of renal transplantation, and affects the prognosis of the kidney and the patient by increasing the risk of arteriosclerosis and cardiovascular complications. The incidence of MetS in Japanese renal transplant recipients is 14.9 to 23.8%, but its effects on cardiovascular events and kidney prognosis are not clear. Here, we report the results of a longitudinal study on MetS in renal transplant recipients. Methods: A retrospective cohort study was conducted in 104 stable renal transplant recipients who attended our outpatient department from January 2006 to June 2007 and were diagnosed with MetS at least 6 months after renal transplantation until 31 December 2020, or did not have MetS. The impact of MetS on composite vascular events was examined using multivariate Cox proportional hazards analysis. Results: The hazard ratios for the impact of MetS on composite vascular events diagnosed by NCEP Japan, NCEP Original, NCEP Asia, and IDF criteria on composite vascular events were 2.78 (95% CI: 1.15 to 6.75, p = 0.024), 2.65 (95% CI: 1.04 to 6.80, p = 0.042), 2.37 (95% CI: 0.93 to 6.01, p = 0.070), and 1.91 (95% CI: 0.77 to 4.75, p = 0.164), respectively. P for interaction was used to test the influence of each indicator, but was not statistically significant. Conclusions: MetS is a robust risk factor for graft loss and development of cardiovascular events in Japanese renal transplant recipients, even during long-term follow-up. This finding emphasizes the importance of monitoring and managing MetS in this population to improve long-term outcomes.<\/jats:p>","DOI":"10.3390\/jcm14155303","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T09:53:02Z","timestamp":1753696382000},"page":"5303","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of Metabolic Syndrome on Renal and Cardiovascular Outcomes in Renal Transplant Recipients: A Single-Center Study in Japan"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4745-8089","authenticated-orcid":false,"given":"Toshihide","family":"Naganuma","sequence":"first","affiliation":[{"name":"Department of Urology, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8586, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2021-0673","authenticated-orcid":false,"given":"Tomoaki","family":"Iwai","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8586, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daijiro","family":"Kabata","sequence":"additional","affiliation":[{"name":"Center for Mathematical and Data Sciences, Kobe University, Kobe 657-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Machida","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8586, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Takemoto","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8586, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Uchida","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8586, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/0003-4819-140-3-200402030-00007","article-title":"The metabolic syndrome and chronic kidney disease in U.S. adults","volume":"140","author":"Chen","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.2337\/diacare.27.10.2444","article-title":"Increasing prevalence of the metabolic syndrome among u.s. Adults","volume":"27","author":"Ford","year":"2004","journal-title":"Diabetes Care"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/sj.ki.5000050","article-title":"Metabolic syndrome and chronic kidney disease in Okinawa, Japan","volume":"69","author":"Tanaka","year":"2006","journal-title":"Kidney Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.metabol.2012.11.002","article-title":"Association of metabolic syndrome and renal insufficiency with clinical outcome in acute myocardial infarction","volume":"62","author":"Kim","year":"2013","journal-title":"Metabolism"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.atherosclerosis.2007.07.037","article-title":"Renal function and metabolic syndrome components on cardiovascular and all-cause mortality","volume":"197","author":"Chien","year":"2008","journal-title":"Atherosclerosis"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/0886022X.2014.964140","article-title":"Association between management of metabolic syndrome and progression of early-stage chronic kidney disease: An observational cohort study","volume":"37","author":"Lin","year":"2015","journal-title":"Ren. Fail."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2215\/CJN.09870912","article-title":"Metabolic syndrome, ESRD, and death in CKD","volume":"8","author":"Navaneethan","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"iii62","DOI":"10.1093\/ndt\/gfh1018","article-title":"Epidemiology of arterial hypertension in renal transplant patients: Changes over the last decade","volume":"19","author":"Campistol","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_10","first-page":"85","article-title":"Single-centre experience with the treatment of high-prevalence metabolic syndrome in kidney transplant patients in Bosnia and Herzegovina","volume":"21","author":"Tulumovic","year":"2024","journal-title":"Med. Glas."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/tri.13783","article-title":"Management of post-transplant diabetes: Immunosuppression, early prevention, and novel antidiabetics","volume":"34","author":"Hecking","year":"2021","journal-title":"Transpl. Int."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1111\/j.1600-6143.2004.00573.x","article-title":"Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease","volume":"4","author":"Schold","year":"2004","journal-title":"Am. J. Transplant."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/ndt\/gfy151","article-title":"Metabolic risk profile in kidney transplant candidates and recipients","volume":"34","author":"Piotti","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/14740338.2020.1732921","article-title":"Treatment of dyslipidemia in kidney transplantation","volume":"19","author":"Ponticelli","year":"2020","journal-title":"Expert. Opin. Drug Saf."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.ajkd.2006.04.078","article-title":"Impact of metabolic syndrome on graft function and survival after cadaveric renal transplantation","volume":"48","author":"Porrini","year":"2006","journal-title":"Am. J. Kidney Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/ckj\/sfx056","article-title":"Cardiovascular effects of metabolic syndrome after transplantation: Convergence of obesity and transplant-related factors","volume":"11","author":"Sgambat","year":"2018","journal-title":"Clin. Kidney J."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Tantisattamo, E., Ho, B.T., and Workeneh, B.T. (2021). Editorial: Metabolic Changes After Kidney Transplantation. Front. Med., 8.","DOI":"10.3389\/fmed.2021.709644"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1600-6143.2007.01749.x","article-title":"Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus","volume":"7","author":"Vincenti","year":"2007","journal-title":"Am. J. Transplant."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1111\/j.1600-6143.2005.01073.x","article-title":"Obesity is associated with worsening cardiovascular risk factor profiles and proteinuria progression in renal transplant recipients","volume":"5","author":"Armstrong","year":"2005","journal-title":"Am. J. Transplant."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/j.1600-6143.2004.00558.x","article-title":"Metabolic syndrome is associated with impaired long-term renal allograft function; not all component criteria contribute equally","volume":"4","author":"Bakker","year":"2004","journal-title":"Am. J. Transplant."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1432-2277.2012.01488.x","article-title":"Clinical diagnosis of metabolic syndrome: Predicting new-onset diabetes, coronary heart disease, and allograft failure late after kidney transplant","volume":"25","author":"Israni","year":"2012","journal-title":"Transpl. Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/ndt\/gfad115","article-title":"Clinical implications of changes in metabolic syndrome status after kidney transplantation: A nationwide prospective cohort study","volume":"38","author":"Lee","year":"2023","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1053\/j.ajkd.2010.01.017","article-title":"Obesity in kidney transplant recipients and candidates","volume":"56","author":"Potluri","year":"2010","journal-title":"Am. J. Kidney Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/tri.12450","article-title":"Metabolic syndrome definitions and components in predicting major adverse cardiovascular events after kidney transplantation","volume":"28","author":"Prasad","year":"2015","journal-title":"Transpl. Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.transproceed.2008.10.091","article-title":"Prevalence of the metabolic syndrome in kidney transplantation","volume":"41","author":"Kishikawa","year":"2009","journal-title":"Transplant. Proc."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1440-1797.2007.00791.x","article-title":"The prevalence of metabolic syndrome in Japanese renal transplant recipients","volume":"12","author":"Naganuma","year":"2007","journal-title":"Nephrology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome--a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/15\/5303\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:16:53Z","timestamp":1760033813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/15\/5303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,27]]},"references-count":29,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["jcm14155303"],"URL":"https:\/\/doi.org\/10.3390\/jcm14155303","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,27]]}}}